Christopher Mutz - Mar 7, 2024 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
HEAD OF RARE DISEASE
Signature
/s/ Christopher Mutz, by attorney-in-fact Meredith W. Cook
Stock symbol
ANIP
Transactions as of
Mar 7, 2024
Transactions value $
-$140,758
Form type
4
Date filed
3/7/2024, 09:16 PM
Previous filing
Mar 6, 2024
Next filing
May 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Tax liability -$141K -2.11K -2.41% $66.71 85.3K Mar 7, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,476 shares of restricted stock, the grant of which was previously reported.